Bortezomib 70710-1411

Product NDC

70710-1411

Manufacturer: Zydus Pharmaceuticals Usa Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: May 2, 2022
Listing Expires: December 31, 2026
Application: ANDA210204

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	1 mg/mL

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Packaging Options(1)

70710-1411-01

1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1411-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE

View →